Sartorius AG (XTER:SRT3) Change In Receivables : €53 Mil (TTM As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Change In Receivables?

Sartorius AG's change in receivables for the quarter that ended in Mar. 2024 was €-75 Mil. It means Sartorius AG's Accounts Receivable increased by €75 Mil from Dec. 2023 to Mar. 2024 .

Sartorius AG's change in receivables for the fiscal year that ended in Dec. 2023 was €169 Mil. It means Sartorius AG's Accounts Receivable declined by €169 Mil from Dec. 2022 to Dec. 2023 .

Sartorius AG's Accounts Receivable for the quarter that ended in Mar. 2024 was €402 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sartorius AG's Days Sales Outstanding for the three months ended in Mar. 2024 was 44.80.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sartorius AG's liquidation value for the three months ended in Mar. 2024 was €-4,907 Mil.

Sartorius AG Change In Receivables Historical Data

The historical data trend for Sartorius AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Change In Receivables Chart

Sartorius AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

18.17

-59.26

-99.10

-86.60

168.60

Sartorius AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															41.50	26.40	52.40	48.30	-74.50

Sartorius AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €53 Mil.

Sartorius AG (XTER:SRT3) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sartorius AG's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	402.4	/	819.6	*	91
=	44.80

2. In Ben Graham's calculation of liquidation value, Sartorius AG's accounts receivable are only considered to be worth 75% of book value:

Sartorius AG's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1146.7	-	6869.1	+	0.75 * 402.4	+	0.5 * 1027.7
=	-4,907

Sartorius AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius AG (XTER:SRT3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT3) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

SOAGY:USA SSSGY:USA SUVPF:USA SARTF:USA 1SRT3:Italy SRT3d:UK 0NIR:UK SRT3:Austria

Address

Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079

Website

https://www.sartorius.com

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Executives

Dr. Joachim Kreuzburg

Board of Directors

Sartorius AG (XTER:SRT3) Headlines

No Headlines